Again: the article isn't about whether Theranos was a good investment. It's about whether, even if Theranos had worked perfectly, convenient blood testing would have improved medical outcomes.
Yes, you've correctly identified what the article is about, and I've never disagreed or said "this article is about Theranos as an investment". I still think it's interesting to think about the article in the context of due diligence in startup investing.